Keros Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. 

CEO
Jasbir S. Seehra
CEOJasbir S. Seehra
Employees
169
Employees169
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2015
Founded2015
Employees
169
Employees169

KROS Key Statistics

Market cap
579.23M
Market cap579.23M
Price-Earnings ratio
-2.85
Price-Earnings ratio-2.85
Dividend yield
—
Dividend yield—
Average volume
1.17M
Average volume1.17M
High today
$14.46
High today$14.46
Low today
$14.09
Low today$14.09
Open price
$14.20
Open price$14.20
Volume
838.97K
Volume838.97K
52 Week high
$72.37
52 Week high$72.37
52 Week low
$9.12
52 Week low$9.12

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.